AlphAIAlphAI — Financial news for AI agents
theglobeandmail.comOCT 61 min read$TLRY

Tilray Brands: TD Cuts Target to C$6.50, Maintains Buy Rating

TD Securities reduced its price target for Tilray Brands to C$6.50 from C$6.75, a 3.7% decrease, while maintaining a Buy rating. The company is set to report Q1 fiscal 2027 results on October 8, with investors focusing on revenue, margins, and cash conversion. International cannabis demand and beverage performance will be key factors.

Original reporting
theglobeandmail.com
Published Oct 6, 2026, 8:49 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 6, 2026, 9:33 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
Tilray Brands: TD Cuts Target to C$6.50, Maintains Buy Rating — source image
Source · theglobeandmail.com
Decision brief

The 30-second read

$TLRYBearishMed
01

Why it matters

The downgrade may prompt short‑term selling but could be offset by the upcoming earnings surprise.

02

Market read

Analyst target changes are a common catalyst for short‑term price moves; this one is modest but relevant ahead of earnings.

03

What to watch

Potential upside from international demand and financing improvements not reflected in the target.

Relevance 6/10Novelty 6/10Timing: pre‑market on Oct 8 ahead of earnings

Background

Tilray Brands is a Canadian‑listed cannabis company with a U.S. ADR (TLRY). The analyst note follows a period of mixed results in the sector.

Company-level read

Ticker impact

$TLRYBearishHigh confidence
Context

TD Securities cut Tilray's price target to C$6.50, a new analyst downgrade ahead of its Q1 earnings release.

Expected impact

potential modest downside as market prices in the lower target

Evidence & confidence

The target cut is a fresh piece of information and signals reduced expectations for revenue and margins.

Market effects

Sector

May weigh on other cannabis stocks as analysts reassess margins.

Regional

Limited to North American cannabis sector.

Global

Low; primarily affects Tilray and peers.

Counterpoint

What could challenge this read

Target cut could be premature if upcoming beverage launch exceeds expectations.

Key entities

  • Company
    Tilray Brands Inc.

    Cannabis, beverage and wellness products producer.

  • Analyst
    TD Securities

    Investment bank providing the price‑target revision.

Read at source← All news

Related articles

OCT 9
$TLRYLow

Should you sell your Tilray stock?

Tilray Brands (TSX:TLRY) reported fiscal Q1 2027 revenue of $257.1M and Adjusted EBITDA of $9.2M, missing analyst estimates. Cannabis revenue fell 13% year-over-year, while beverage alcohol revenue rose 82.1%. Analyst Neal Gilmer maintained a 'Hold' rating and $4.00 target, citing concerns about organic growth and cash flow.

cantechletter.com2 min
OCT 9
$TLRYMed

Tilray Brands revenue rises 20% in Q1 2027

Tilray Brands reported a 20% revenue increase to $257.1M in Q1 2027, driven by beverage sales. Gross profit rose 35% to $77.5M. Beverage revenue grew 82% to $101.5M, while cannabis revenue declined. The company reported a net loss of $40M but reduced debt by $42M. Tilray reaffirmed its adjusted EBITDA guidance of $68M-$75M for the fiscal year.

foodbusinessmea.com2 min
OCT 9
$TLRYMedAI 8/10

Tilray (TLRY) Q1 2027 Earnings Call Transcript

Tilray (TLRY) reported Q1 2027 revenue of $257 million, up 23% YoY, with expanded gross margins. The company highlighted its global scale, leadership in cannabis, beverage, and wellness, and strategic acquisitions like BrewDog. Tilray emphasized its diversified business model, international growth, and cost reductions in key markets like Portugal and Germany.

finance.yahoo.com2 min
OCT 8
$TLRYMedAI 8/10

Tilray Brands Inc (TLRY) (Q1 2027) Earnings Call Highlights: Record Revenue

Tilray Brands Inc (TLRY) reported a Q1 net loss of $40M, down from a $1.5M profit last year, due to higher marketing costs and fuel surcharges. Revenue was impacted by cannabis price compression, supply constraints, and inventory shifts. BrewDog turned profitable, and the company expects continued growth. Tilray also discussed partnerships, international expansion, and potential M&A opportunities.

finance.yahoo.com2 min
OCT 8
$TLRYHigh

Tilray Brands swings to $40M loss as revenue rises

Tilray Brands reported a net loss of $40.0 million for Q2 2026, despite revenue growth to $257.1 million. Gross profit rose to $77.5 million, but operating loss was $24.1 million. Cannabis revenue declined, while beverage revenue increased. The company issued shares to repay debt and amended credit agreements to ease covenant testing.

stocktitan.net2 min